Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211172 · ClinicalTrials.gov registry record · NA
HMO Research Network CERT: Acute Myocardial Infarction
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 836
- Enrollment target
NCT00211172 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 836 participants.
The verdict
NCT00211172, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 836 participants
- Enrollment target
Study Summary
The primary goal of this study is to evaluate the effectiveness of direct-to-patient mailings designed to increase patient's adherence to prescribed beta-blockers following an acute myocardial infarction (AMI). Prior to developing patient materials, focus groups were conducted with patient who had previously suffered an acute myocardial infarction (AMI) to identify the issues and information that patients felt were important to include in our materials as well as the best way to present the information. Additionally, patient materials were "pre-tested" with AMI patients to ensure that the materials were clear and easy to read and that the key messages were understood.
Interventions
- BEHAVIORAL Beta-blocker adherence after an AMI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 836 participants |
| Start Date | 2003-10 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211172
The ClinicalTrials.gov registry entry for NCT00211172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 836 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Beta-blocker adherence after an AMI is the first listed.
NCT00211172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00211172 about?
NCT00211172 is a clinical study titled "HMO Research Network CERT: Acute Myocardial Infarction". The primary goal of this study is to evaluate the effectiveness of direct-to-patient mailings designed to increase patient's adherence to prescribed beta-blockers following an acute myocardial infarction (AMI). Prior to developing patient materials, focus groups were conducted with patient who had ...
What is the current status of trial NCT00211172?
This trial is currently completed. It is a NA study. The enrollment target is 836 participants. The study started on 2003-10. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00211172?
The interventions under investigation include: Beta-blocker adherence after an AMI (BEHAVIORAL).
Who is sponsoring clinical trial NCT00211172?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.